Abstract
Understanding how risk factors interact to jointly influence disease risk can provide insights into disease development and improve risk prediction. Here we introduce survivalFM, a machine learning extension to the widely used Cox proportional hazards model that enables scalable estimation of all potential pairwise interaction effects on time-to-event outcomes. The method approximates interaction effects using a low-rank factorization, allowing it to overcome the computational and statistical limitations typically associated with high-dimensional interaction modeling. Applied to the UK Biobank dataset across nine disease examples and diverse clinical and omics risk factors, survivalFM improves prediction performance in terms of discrimination, explained variation, and reclassification in 30.6%, 41.7%, and 94.4% of the scenarios tested, respectively. In a clinical cardiovascular risk prediction scenario using the established QRISK3 model, the method adds predictive value by identifying interactions beyond the age interaction effects currently included. These results demonstrate that comprehensive modeling of interactions can facilitate advanced insights into disease development and improve risk predictions.
| Original language | English |
|---|---|
| Article number | 6620 |
| Pages (from-to) | 1-15 |
| Number of pages | 15 |
| Journal | Nature Communications |
| Volume | 16 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Dec 2025 |
| MoE publication type | A1 Journal article-refereed |
Funding
This work was supported by the Research Council of Finland grants 339421 (Machine Learning for Systems Pharmacology, MASF, 2021-2025) and 345802 (AI technologies for interaction prediction in biomedicine, AIB, 2022-2024) to J.R. and Technology Industries of Finland Centennial Foundation funding (Aalto University House of AI) to H.J. The authors acknowledge the computational resources provided by the Aalto Science-IT project.
Projects
- 2 Finished
-
AIB: AI technologies for interaction prediction in biomedicine (AIB)
Rousu, J. (Principal investigator), Huusari, R. (Project Member), Szedmak, S. (Project Member) & Julkunen, H. (Project Member)
01/01/2022 → 31/12/2024
Project: RCF Academy Project targeted call
-
MASF: Machine Learning for Systems Pharmacology (MASF)
Rousu, J. (Principal investigator), Midena, G. (Project Member), Tulkki, I. (Project Member), Li, A. (Project Member), Julkunen, H. (Project Member), Armah-Sekum, R. (Project Member) & Szedmak, S. (Project Member)
01/09/2021 → 31/08/2025
Project: RCF Academy Project
Equipment
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver